![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Buy article online]](/logos/buy.gif)
![[Contents scheme]](cv6142contents.gif)
Acta Cryst. (2002). E58, o1062-o1064 [ doi:10.1107/S1600536802015842 ]
Abstract: The crystal structure of the title compound, C17H14Cl2FN3O·H2O, is stabilized by hydrogen bonds. The morpholine ring exhibits a typical chair conformation, while the benzimidazole system is planar.
Online 13 September 2002
Copyright © International Union of Crystallography
IUCr Webmaster